Custom oligos

Introduction The global landscape of oligonucleotide manufacturing companies is rapidly evolving as more developers choose to outsource production to specialized partners. This shift is largely driven by the significant capital investment required for synthesis instruments, analytical platforms, and purification facilities, making collaboration with an experienced oligonucleotide CDMO a more efficient and scalable solution. We have […]